Antonello D'Andrea

Prof. Antonello D'Andrea

Department of Cardiology, Umberto I Hospital, 84014 Nocera Inferiore, SA, Italy
orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2010 in American Heart Journal
Verified
Journal Article
Closed access
Antonello D'AndreaAntonello D'Andrea
Antonello D'Andrea
LRLucia Riegler
Lucia Riegler
RCRosangela Cocchia
Rosangela Cocchia
RSRaffaella Scarafile
Raffaella Scarafile
GSGemma Salerno
Gemma Salerno
RCRaffaele Calabrò
Raffaele Calabrò

18 December 2006 in British Journal of Sports Medicine
Verified
Journal Article
Closed access
Antonello D'AndreaAntonello D'Andrea
Antonello D'Andrea
PCPio Caso
Pio Caso
GSGemma Salerno
Gemma Salerno
RSRaffaella Scarafile
Raffaella Scarafile
GCGiuseppe De Corato
Giuseppe De Corato
RCRaffaele Calabrò
Raffaele Calabrò
Background: Anabolic androgenic steroids (AAS) are sometimes used by power athletes to improve performance by increasing muscle mass and strength. Recent bioptical data have shown that in athletes under the pharmacological effects of AAS, a focal increase in myocardial collagen content might occur as a repair mechanism against myocardial damage. Objective: To investigate the potential underlying left ventricular myocardial dysfunction after chronic misuse of AAS in athletes by use of Doppler myocardial imaging (DMI) and strain rate imaging (SRI). Methods: Standard Doppler echocardiography, DMI, SRI and ECG treadmill test were undertaken by 45 bodybuilders, including 20 athletes misusing AAS for at least 5 years (users), by 25 anabolic-free bodybuilders (non-users) and by 25 age-matched healthy sedentary controls, all men. The mean (SD) number of weeks of AAS use per year was 31.3 (6.4) in users, compared with 8.9 (3.8) years in non-users, and the mean weekly dosage of AAS was 525.4 (90.7) mg. Results: The groups were matched for age. Systolic blood pressure was higher in athletes (145 (9) vs 130 (5) mm Hg) than in controls. Left ventricular mass index did not significantly differ between the two groups of athletes. In particular, both users and non-users showed increased wall thickness and relative wall thickness compared with controls, whereas left ventricular ejection fraction, left ventricular end-diastolic diameter and transmitral Doppler indexes were comparable for the three groups. Colour DMI analysis showed significantly lower myocardial early: myocardial atrial diastolic wave ratios in users at the level of the basal interventricular septum (IVS) and left ventricular lateral wall (p<0.01), in comparison with both non-users and controls. In addition, in users, peak systolic left ventricular strain rate and strain were both reduced in the middle IVS (both p<0.001) and in the left ventricular lateral free wall (both p<0.01). By stepwise forward multivariate analyses, the sum of the left ventricular wall thickness (β coefficient = −0.32, p<0.01), the number of weeks of AAS use per year (β = −0.42, p<0.001) and the weekly dosage of AAS (β = −0.48, p<0.001) were the only independent determinants of middle IVS strain rate. In addition, impaired left ventricular strain in users was associated with a reduced performance during physical effort (p<0.001). Conclusions: Several years after chronic misuse of AAS, power athletes show a subclinical impairment of both systolic and diastolic myocardial function, strongly associated with mean dosage and duration of AAS use. The combined use of DMI and SRI may therefore be useful for the early identification of patients with more diffused cardiac involvement, and eventually for investigation of the reversibility of such myocardial effects after discontinuation of the drug.

1 March 2013 in International Journal of Cardiology
Verified
Journal Article
Closed access
Antonello D'AndreaAntonello D'Andrea
Antonello D'Andrea
LRLucia Riegler
Lucia Riegler
EGEnrica Golia
Enrica Golia
RCRosangela Cocchia
Rosangela Cocchia
RSRaffaella Scarafile
Raffaella Scarafile
EBEduardo Bossone
Eduardo Bossone

1 January 2016 in World Journal of Cardiology
Verified
Journal Article
Open access
Antonello D'AndreaAntonello D'Andrea
Antonello D'Andrea
MCMarianna Conte
Marianna Conte
MCMassimo Cavallaro
Massimo Cavallaro
RSRaffaella Scarafile
Raffaella Scarafile
LRLucia Riegler
Lucia Riegler
RCRaffaele Calabrò
Raffaele Calabrò
Non-invasive Doppler ultrasonographic study of cerebral arteries [transcranial Doppler (TCD)] has been extensively applied on both outpatient and inpatient settings. It is performed placing a low-frequency (≤ 2 MHz) transducer on the scalp of the patient over specific acoustic windows, in order to visualize the intracranial arterial vessels and to evaluate the cerebral blood flow velocity and its alteration in many different conditions. Nowadays the most widespread indication for TCD in outpatient setting is the research of right to left shunting, responsable of so called “paradoxical embolism”, most often due to patency of foramen ovale which is responsable of the majority of cryptogenic strokes occuring in patients younger than 55 years old. TCD also allows to classify the grade of severity of such shunts using the so called “microembolic signal grading score”. In addition TCD has found many useful applications in neurocritical care practice. It is useful on both adults and children for day-to-day bedside assessment of critical conditions including vasospasm in subarachnoidal haemorrhage (caused by aneurysm rupture or traumatic injury), traumatic brain injury, brain stem death. It is used also to evaluate cerebral hemodynamic changes after stroke. It also allows to investigate cerebral pressure autoregulation and for the clinical evaluation of cerebral autoregulatory reserve.

24 October 2007 in European Heart Journal
Verified
Journal Article
Open access
PDF file
Antonello D'AndreaAntonello D'Andrea
Antonello D'Andrea
PCPio Caso
Pio Caso
SRSilvio Romano
Silvio Romano
RSRaffaella Scarafile
Raffaella Scarafile
LRLucia Riegler
Lucia Riegler
RCRaffaele Calabrò
Raffaele Calabrò
In dilated cardiomyopathy (DCM), attenuation of left atrial (LA) booster pump function has been observed, and attributed both to altered LA loading conditions owing to left ventricular (LV) diastolic dysfunction and to LA involvement in the myopathic process. The aim of the present study was to detect LA systolic dysfunction in DCM using speckle-tracking two-dimensional strain echocardiography (2DSE), and to assess the effects of cardiac resynchronization therapy (CRT) on LA myocardial strain during 6 month follow-up. A total of 90 patients (aged, 52.4 ± 10.2 years) with either idiopathic (n = 47) or ischaemic (n = 43) DCM underwent standard Doppler echo and 2DSE analysis of atrial longitudinal strain in the basal segments of LA septum and LA lateral wall, and in LA roof. The two groups were comparable for clinical variables (NYHA class: III in 72.2%; IV in 27.8%). LV volumes, ejection fraction, stroke volume, and mitral valve effective regurgitant orifice were similar between the two groups. No significant differences were evidenced in Doppler transmitral inflow measurements. LA diameter and maximal volume were also similar between the two groups. Conversely, LA active emptying volume and fraction were both lower in patients with idiopathic DCM. Peak systolic myocardial atrial strain was significantly compromised in patients with idiopathic DCM compared with ischaemic DCM in all the analysed atrial segments (P < 0.001). At follow-up, 64 patients (71.1%) (37 idiopathic and 27 ischaemic) were responders, and 26 (28.9%) (10 idiopathic; 16 ischaemic) were non-responders to CRT (responder: decrease of LV end-systolic volume >15%). A significant improvement in LA systolic function was obtained only in patients with ischaemic DCM responders to CRT (P < 0.001). By multivariable analysis, in the overall population, it was found that ischaemic aetiology of DCM (β-cofficient = 0.62; P < 0.0001) and positive response to CRT (β-cofficient = 0.42; P < 0.01) were the only independent determinants of LA lateral wall systolic strain. Two-dimensional strain represents a promising non-invasive technique to assess LA atrial myocardial function in patients with DCM. LA pump and reservoir function at baseline and after CRT are more depressed in idiopathic compared with ischaemic DCM patients. Future longitudinal studies are warranted to understand further the natural history of LA myocardial function, the extent of reversibility of LA dysfunction with CRT, and the possible prognostic impact of such indexes in patients with congestive heart failure.

29 September 2021 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
Federica IlardiFederica Ilardi
Federica Ilardi
Antonello D'AndreaAntonello D'Andrea
Antonello D'Andrea
Flavio D'AscenziFlavio D'Ascenzi
Flavio D'Ascenzi
FBFrancesco Bandera
Francesco Bandera
GBGiovanni Benfari
Giovanni Benfari
O(on behalf of the Working Group of Echocardiography of the Italian Society of Cardiology (SIC)
on behalf of the Working Group of Echocardiography of the Italian Society of Cardiology (SIC)
Left ventricular (LV) global longitudinal strain (GLS) has established itself in the last decade as a reliable, more objective method for the evaluation of LV systolic function, able to detect subtle abnormalities in LV contraction even in the presence of preserved ejection fraction (EF). However, recent studies have demonstrated that GLS, similar to LV EF, has important load dependency. Non-invasive myocardial work (MW) quantification has emerged in the last years as an alternative tool for myocardial function assessment. This new method, incorporating measurement of strain and LV pressure, has shown to overcome GLS and LV EF limitations and provide a loading-independent evaluation of myocardial performance. The presence of a commercially available echocardiographic software for the non-invasive MW calculation has allowed the application of this new method in different settings. This review sought to provide an overview on the current knowledge of non-invasive MW estimation, showing its potential applications and possible added value in clinical practice.